Hikurangi Cannabis signs $160mn, multi-tonne deal to supply USA’s Rhizo Sciences

By Addie Thomes

New Zealand pharmaceutical cannabis firm Hikurangi Cannabis has agreed to produce and export tonnes of medical cannabis to American company Rhizo Sciences.

Based in Ruatoria, Hikurangi will produce three tonnes next year, rising to 12 tonnes a year by 2021. Currently, it has a crop of around 5,000 plants.

Rhizo Sciences works with licensed processors and investors to develop large scale production and export facilities to supply the growing demand for medical cannabis.

See also:

The Seattle-based company is developing a global network of growers, manufacturers and distributors to of wholesale cannabis flower, extracts and cannabis medicines to distribute internationally including the United States, Canada, Australia, Israel, Europe, the UK, Africa and South America.

Hikurangi Hemp managing director Manu Caddie said: “Having a partner with deep industry knowledge and global customers provides exciting opportunities for our young company. This relationship will enable us to export product potentially worth tens of millions every year.”

Rhizo Sciences Co-founder and President Dr Dallas McMillan added: “Hikurangi have demonstrated their commitment to world class production standards and the clinical trials they have planned for this year will be world-leading.

“We want to be able offer our customers clean, green New Zealand product and an integrated company like Hikurangi Group offer the perfect partner.”

The deal is subject to legislation being passed in New Zealand, something which both parties appear confident will happen without any mishaps.

Share

Featured Articles

Hybrid live event shaping the future of Sustainability & ESG

Sustainability LIVE London returns for a two-day, multi-track conference programme featuring inspirational ESG speakers, debates and discussions

Nine must-attend sustainability events for business leaders

From London to Abu Dhabi, Singapore to San Diego, these sustainability-focused events are designed to help business leaders action their ESG goals

Daniel Weise of BCG on new supply chain and procurement book

Daniel Weise, global leader of Boston Consulting Group’s procurement business line, on the timely publication of his new book, Profit From The Source

Attract and retain talent with flexible working and benefits

Human Capital

Nurturing the next generation of women leaders in Africa

Leadership & Strategy

5 Mins With: Cybersecurity expert Ariel Parnes of Mitiga

Technology